Vivek Kumar Garg
Overview
Explore the profile of Vivek Kumar Garg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
783
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garg V, Joshi H, Sharma A, Yadav K, Yadav V
Peptides
. 2024 Nov;
182:171320.
PMID: 39547414
Antimicrobial peptides (AMPs), particularly host defense peptides (HDPs), have gained recognition for their role in host defense mechanisms, but they have also shown potential as a promising anticancer, antiviral, antiparasitic,...
2.
Yadav V, Singh T, Sharma D, Garg V, Chakraborty P, Ghatak S, et al.
Cancers (Basel)
. 2024 Sep;
16(18).
PMID: 39335155
Colorectal cancer (CRC) remains a significant global health burden with high incidence and mortality. MicroRNAs (miRNAs) are small non-protein coding transcripts, conserved throughout evolution, with an important role in CRC...
3.
Naik S, Kashyap D, Deep J, Darwish S, Cross J, Mansoor E, et al.
Diagnostics (Basel)
. 2024 Aug;
14(15).
PMID: 39125540
Next-generation sequencing (NGS) has emerged as a promising tool for diagnosing fungal infections. It enables the identification of a wide range of fungal species and provides more accurate and rapid...
4.
Correction: Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives
Tuli H, Garg V, Kumar A, Aggarwal D, Anand U, Parashar N, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Apr;
397(6):4475.
PMID: 38619590
No abstract available.
5.
Kumari A, Kashyap D, Garg V
Adv Clin Chem
. 2024 Jan;
118:87-110.
PMID: 38280808
Osteopontin (OPN) is a heavily post-translationally modified protein with a molecular weight of 44-70 kDa, depending on the degree of glycosylation. OPN is involved in various biological processes, including bone...
6.
Garg V, Buttar H, Bhat S, Ainur N, Priya T, Kashyap D, et al.
Recent Adv Inflamm Allergy Drug Discov
. 2023 Aug;
17(2):110-120.
PMID: 37605396
Both Stevens-johnson syndrome (SJS) and Toxic-epidermal necrolysis (TEN) are generally medication-induced pathological conditions that mostly affect the epidermis and mucus membranes. Nearly 1 to 2 patients per 1,000,000 population are...
7.
Kashyap D, Sharma R, Goel N, Buttar H, Garg V, Pal D, et al.
Front Genet
. 2023 Jan;
13:993687.
PMID: 36685962
Dysregulation of epigenetic mechanisms have been depicted in several pathological consequence such as cancer. Different modes of epigenetic regulation (DNA methylation (hypomethylation or hypermethylation of promotor), histone modifications, abnormal expression...
8.
Tuli H, Sak K, Garg V, Kumar A, Adhikary S, Kaur G, et al.
Toxicol Rep
. 2022 Dec;
9:1614-1623.
PMID: 36561961
Cancer is being considered as a serious threat to human health globally due to limited availability and efficacy of therapeutics. In addition, existing chemotherapeutic drugs possess a diverse range of...
9.
Tuli H, Garg V, Mehta J, Kaur G, Mohapatra R, Dhama K, et al.
Onco Targets Ther
. 2022 Dec;
15:1419-1448.
PMID: 36474507
Cancer is a highly lethal disease, and its incidence has rapidly increased worldwide over the past few decades. Although chemotherapeutics and surgery are widely used in clinical settings, they are...
10.
Tuli H, Garg V, Bhushan S, Uttam V, Sharma U, Jain A, et al.
Transl Oncol
. 2022 Dec;
27:101596.
PMID: 36473401
Cancer prevalence and its rate of incidence are constantly rising since the past few decades. Owing to the toxicity of present-day antineoplastic drugs, it is imperative to explore safer and...